phloroglucinol has been researched along with Lung Neoplasms in 5 studies
Phloroglucinol: A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent.
phloroglucinol : A benzenetriol with hydroxy groups at position 1, 3 and 5.
Lung Neoplasms: Tumors or cancer of the LUNG.
Excerpt | Relevance | Reference |
---|---|---|
"The microbial polyketide, 2, 4-diacetylphloroglucinol (DAPG), exhibited a broad-spectrum of anti-leukemic, anti-lung, and anti-breast cancer properties." | 7.83 | Anti-leukemic, anti-lung, and anti-breast cancer potential of the microbial polyketide 2, 4-diacetylphloroglucinol (DAPG) and its interaction with the metastatic proteins than the antiapoptotic Bcl-2 proteins. ( Kennedy, K; Krishna, R; Lakshmi, P; Sakthivel, N; Veena, VK, 2016) |
"Treatment with phloroglucinol effectively inhibited mesenchymal phenotypes of basal type breast cancer cells through downregulation of SLUG without causing a cytotoxic effect." | 5.42 | Phloroglucinol suppresses metastatic ability of breast cancer cells by inhibition of epithelial-mesenchymal cell transition. ( Cui, YH; Hwang, E; Kang, JS; Kim, HJ; Kim, MJ; Kim, RK; Lee, SJ; Lee, YY; Suh, Y; Yoo, KC, 2015) |
"The microbial polyketide, 2, 4-diacetylphloroglucinol (DAPG), exhibited a broad-spectrum of anti-leukemic, anti-lung, and anti-breast cancer properties." | 3.83 | Anti-leukemic, anti-lung, and anti-breast cancer potential of the microbial polyketide 2, 4-diacetylphloroglucinol (DAPG) and its interaction with the metastatic proteins than the antiapoptotic Bcl-2 proteins. ( Kennedy, K; Krishna, R; Lakshmi, P; Sakthivel, N; Veena, VK, 2016) |
"Treatment with phloroglucinol effectively inhibited mesenchymal phenotypes of basal type breast cancer cells through downregulation of SLUG without causing a cytotoxic effect." | 1.42 | Phloroglucinol suppresses metastatic ability of breast cancer cells by inhibition of epithelial-mesenchymal cell transition. ( Cui, YH; Hwang, E; Kang, JS; Kim, HJ; Kim, MJ; Kim, RK; Lee, SJ; Lee, YY; Suh, Y; Yoo, KC, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, WT | 1 |
Chen, YK | 1 |
Lin, SS | 1 |
Hsu, FT | 1 |
Kim, RK | 1 |
Suh, Y | 1 |
Yoo, KC | 1 |
Cui, YH | 1 |
Hwang, E | 1 |
Kim, HJ | 1 |
Kang, JS | 1 |
Kim, MJ | 1 |
Lee, YY | 1 |
Lee, SJ | 1 |
Veena, VK | 1 |
Kennedy, K | 1 |
Lakshmi, P | 1 |
Krishna, R | 1 |
Sakthivel, N | 1 |
Donà, M | 1 |
Dell'Aica, I | 1 |
Pezzato, E | 1 |
Sartor, L | 1 |
Calabrese, F | 1 |
Della Barbera, M | 1 |
Donella-Deana, A | 1 |
Appendino, G | 1 |
Borsarini, A | 1 |
Caniato, R | 1 |
Garbisa, S | 1 |
Takasaki, M | 1 |
Konoshima, T | 1 |
Etoh, H | 1 |
Pal Singh, I | 1 |
Tokuda, H | 1 |
Nishino, H | 1 |
5 other studies available for phloroglucinol and Lung Neoplasms
Article | Year |
---|---|
Hyperforin Suppresses Tumor Growth and NF-κB-mediated Anti-apoptotic and Invasive Potential of Non-small Cell Lung Cancer.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Mov | 2018 |
Phloroglucinol suppresses metastatic ability of breast cancer cells by inhibition of epithelial-mesenchymal cell transition.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Movement; Epithelial-Mesenchymal Transition; | 2015 |
Anti-leukemic, anti-lung, and anti-breast cancer potential of the microbial polyketide 2, 4-diacetylphloroglucinol (DAPG) and its interaction with the metastatic proteins than the antiapoptotic Bcl-2 proteins.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Humans; Leukemia; Lung Neoplasms; Molecul | 2016 |
Hyperforin inhibits cancer invasion and metastasis.
Topics: Adenocarcinoma; Animals; Apoptosis; Bridged Bicyclo Compounds; Cell Division; Cell Survival; Colonic | 2004 |
Cancer chemopreventive activity of euglobal-G1 from leaves of Eucalyptus grandis.
Topics: 4-Nitroquinoline-1-oxide; 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Antivi | 2000 |